Research and Development

Showing 15 posts of 9603 posts found.

Medical Devices: Harmonisation of Requirements for Address of Manufacturer

October 19, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

The inclusion of the manufacturer’s address on the labels and instructions for use is an Essential Requirement according to the …

Opportunity to Realise the Value of Dormant UK Authorisations before December Deadline

October 19, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Holders wishing to cancel their authorisations, registrations and licences are required to notify the MHRA by 31 December 2011 to …
malaria vaccine trial

GSK malaria vaccine cuts disease risk by half

October 19, 2011 Research and Development malaria, malaria vaccine

Results from GSK’s malaria vaccine trial have excited observers after it reduced the risk of the disease by half. Data …

European judge rules against stem cell patents

October 19, 2011 Research and Development Stem cells, patents

The European Court of Justice has ruled that stem cells cannot be patented, representing a major blow to research in …
ralf_huss

German biotech Apceth appoints Prof. Ralf Huss

October 19, 2011 Research and Development appointment, research and development

Munich-based biotech Apceth has appointed Prof Ralf Huss to its management board. Prof Huss moves to the company from Roche, …
Lundbeck headquarters, Denmark

Lundbeck establishes research centre in China

October 18, 2011 Research and Development Brain disorders, CNS, China, Lundbeck, Shanghai, emerging markets

Lundbeck has set up a new research centre in China, joining a wave of pharma companies investing in the region. The …

EMA resources stretched by Mediator scandal

October 18, 2011 Research and Development, Sales and Marketing EMA, Mediator

The European Medicines Agency has been forced to use ‘considerable resources’ to deal with a flood of enquiries over Mediator …
Roche

Roche buys US firm Anadys for $230 million

October 17, 2011 Research and Development, Sales and Marketing Roche, hepatitis C

Roche has acquired US firm Anadys for $230 million, bolstering its infectious drugs pipeline. California-based Anadys develops oral, small molecule …

Quintiles opens new European headquarters in the UK

October 12, 2011 Research and Development Quintiles, research and development news

Pharmaceutical services company Quintiles has opened a new European headquarters in the UK. The Reading, Berkshire facility will house more …
India

India will scrutinise foreign investment in pharma

October 11, 2011 Manufacturing and Production, Research and Development, Sales and Marketing India, Indian pharmaceutical industry

The Indian government has decided not to put any restrictions on the level of foreign direct investment (FDI) in the …

Parexel to work with Singapore on clinical research training

October 11, 2011 Research and Development Asia, CRO, Parexel, Singapore, clinical research

Parexel and the National University of Singapore have launched a new academic course to train Asia’s scientist to work in …
merck_co_richard_clark

Merck & Co chairman Richard Clark retires

October 10, 2011 Research and Development, Sales and Marketing appointment, sales and marketing

Richard Clark will step down as chairman of Merck & Co on 1 December after leading the company for six …
Boehringer

Boehringer signs away HIV rights to focus on hep C

October 7, 2011 Research and Development Boehringer, Gilead, HIV, hepatitis C

Boehringer Ingelheim has signed a deal giving Gilead Sciences exclusive worldwide rights to a major part of its HIV portfolio. …

UK funding boost for early-stage research

October 7, 2011 Research and Development NIHR, UK science

The government has established a new research institute to aid public and private groups working on the early stages of …
European Parliament

EMA tightens conflict of interest rules

October 6, 2011 Research and Development, Sales and Marketing EMA

The European Medicines Agency is tightening up its conflict of interest rules with a new ‘experts database’. This will allow …
The Gateway to Local Adoption Series

Latest content